Milestone Pharmaceuticals Inc.
MIST
Rank in Stocks
#20050
Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in... Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and therapeutic applications in humans. The company was founded in 2003.
Share Price
$0.738
Last synced: 2026-11-09
Market Cap
$91.88M
Change (1 day)
-3.25%
Change (1 year)
-61.36%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Milestone Pharmaceuticals Inc. (MIST)
Category
Healthcare
Operating Margin for Milestone Pharmaceuticals Inc. (MIST)
Operating Margin as of November 2026 TTM: -3,353.01%
According to Milestone Pharmaceuticals Inc.'s latest financial reports, its current operating margin (TTM) is -3,353.01%. At the end of 2025 the company had an operating margin of -4,041.72%.
Operating Margin history for Milestone Pharmaceuticals Inc. from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3,353.01% | -17.04% |
| 2025 | -4,041.72% | 0.00% |
| 2024 | 0.00% | -100.00% |
| 2023 | -6,109.80% | 412.21% |
| 2022 | -1,192.84% | 315.41% |
| 2021 | -287.15% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.01% |
US
|
|
| -149.01% | -99.96% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.01% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Milestone Pharmaceuticals Inc.'s operating margin
What is Milestone Pharmaceuticals Inc.'s operating margin?
Milestone Pharmaceuticals Inc.'s operating margin is -3,353.01%, as of Nov 2026.
What was Milestone Pharmaceuticals Inc.'s operating margin in 2025?
In 2025, Milestone Pharmaceuticals Inc.'s operating margin was -4,041.72%, compared with 0.00% in 2024.
How has Milestone Pharmaceuticals Inc.'s operating margin changed since 2020?
From 2020 to 2025, Milestone Pharmaceuticals Inc.'s operating margin was highest in 2024 (0.00%) and lowest in 2023 (-6,109.80%).
How does Milestone Pharmaceuticals Inc.'s operating margin compare with similar companies?
Milestone Pharmaceuticals Inc.'s operating margin (-3,353.01%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.